Skip to main content

WELLS FARGO & COMPANY/MN

Position in FLNA — Filana Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in FLNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,454
-$1,777 QoQ
Shares Held
10,466
+24.3% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 84 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLNA Over Time

Shares Held

Position Value (USD)

Derivatives in FLNA

reported options exposure · as of Sep 30, 2022
CallValue
$0
CallShares
0
PutValue
$418,200
PutShares
10,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. FLNA ranks #315 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLNA

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,454 10,466
2026-03-31 $14,231 8,421
2025-12-31 $32,280 16,304
2025-09-30 $57,859 19,883
2025-06-30 $42,321 23,383
2025-03-31 $38,431 25,621
2024-12-31 $70,808 30,004
2024-09-30 $764,001 25,960
2024-06-30 $216,742 17,550
2024-03-31 $331,821 16,354
2023-12-31 $319,190 14,180
2023-09-30 $208,680 12,541
2023-06-30 $494,812 20,180
2023-03-31 $255,478 10,592
2022-12-31 $95,235 3,224
2022-09-30 $149,631 3,578
2022-09-30 $418,200 10,000
2022-06-30 $64,422 2,291
2022-03-31 $374,146 10,074
2021-12-31 $1,761,108 40,300
2021-09-30 $1,581,611 25,477
2021-06-30 $1,288,519 15,081
2021-03-31 $1,522,185 33,864
2020-12-31 $1,122,372 164,571
2020-09-30 $659,348 57,285
2020-06-30 $129,993 42,206
2020-03-31 $11,494 2,797